Company news from ShareCast

Ocado completes 600m pound convertible bond sale

Mon 09 December 2019 18:47

(Sharecast News) - Online grocer Ocado closed a £600.0m convertible bond offering at the start of the week.

Tuesday preview: MRP poll and China CPI in focus

Mon 09 December 2019 15:49

(Sharecast News) - The focus on Tuesday will be on the release of YouGov's closely-followed MRP poll of voting intentions at 2200 GMT, as investors try to anticipate the result of the next general election, on Thursday.

Merck to buy ArQule in $2.7bn cash deal

Mon 09 December 2019 12:39

(Sharecast News) - Merck has agreed to buy biopharmaceutical group ArQule in a $2.7bn cash deal.

Predator enters into rig option to drill Guercif permits

Mon 09 December 2019 09:56

(Sharecast News) - Jersey-based Predator Oil & Gas Holdings updated the market on its drilling plans for the Guercif Permits I, II, III and IV, onshore Morocco on Monday.

HSBC makes management changes for 'next phase of strategy'

Mon 09 December 2019 09:44

(Sharecast News) - HSBC Holdings announced a number of changes to its senior management team on Monday, which it said would position the banking giant for the next phase of its strategy.

Amigo Holdings CEO to step down

Mon 09 December 2019 09:38

(Sharecast News) - Guarantor loans provider Amigo Holdings has announced the resignation of its chief executive officer, Hamish Paton.

PureTech affiliate Gelesis secures $84.6m in new capital

Mon 09 December 2019 09:37

(Sharecast News) - Biotechnology commercialisation company PureTech Health noted on Monday that its affiliate Gelesis had secured $84.6m (£64.26m) in new capital.

Prosus sweetens offer for Just Eat to ?5.1bn

Mon 09 December 2019 08:01

(Sharecast News) - Prosus sweetened its offer for online food delivery firm Just Eat on Monday to £5.1bn from £4.9bn.

Sanofi to buy Synthorx in $2.4bn cash deal

Mon 09 December 2019 07:45

(Sharecast News) - French pharmaceutical company Sanofi has agreed to buy US biotechnology group Synthorx Inc in a $2.4bn cash deal as it looks to bolster its immuno-oncology pipeline.

RBC Capital downgrades ConvaTec after share price strength

Mon 09 December 2019 07:28

(Sharecast News) - RBC Capital Markets downgraded its stance on shares of medical products and technologies company ConvaTec to 'sector perform' from 'outperform' on Monday, cutting the price target to 197p from 210p following recent share price strength.